BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2642513)

  • 1. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light.
    Yang XY; Gasparro FP; DeLeo VA; Santella RM
    J Invest Dermatol; 1989 Jan; 92(1):59-63. PubMed ID: 2642513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantification of 8-methoxypsoralen-DNA adducts.
    Santella RM; Yang XY; DeLeo VA; Gasparro FP
    IARC Sci Publ; 1988; (89):333-40. PubMed ID: 3058601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological detection and visualization of 8-methoxypsoralen-DNA photoadducts.
    Yang XY; DeLeo V; Santella RM
    Cancer Res; 1987 May; 47(9):2451-5. PubMed ID: 2436765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic localization of 8-methoxypsoralen in psoriasis skin in vitro.
    Bertaux B; Dubertret L; Moreno G
    Acta Derm Venereol; 1981; 61(6):481-5. PubMed ID: 6177157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.
    Deeni YY; Ibbotson SH; Woods JA; Wolf CR; Smith G
    PLoS One; 2013; 8(9):e75494. PubMed ID: 24086543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraindividual and interindividual variability in 8-methoxypsoralen kinetics and effect in psoriatic patients.
    Herfst MJ; De Wolff FA
    Clin Pharmacol Ther; 1983 Jul; 34(1):117-24. PubMed ID: 6861433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair elicited by UVB during PUVA therapy for psoriasis.
    Bishop SC; Abel EA
    Arch Dermatol Res; 1985; 278(1):25-30. PubMed ID: 4096527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of DNA-psoralen photoadducts in mammalian skin.
    Pathak MA; Zarebska Z; Mihm MC; Jarzabek-Chorzelska M; Chorzelski T; Jablonska S
    J Invest Dermatol; 1986 Mar; 86(3):308-15. PubMed ID: 2427607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).
    Ravenscroft J; Goulden V; Wilkinson M
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S218-9. PubMed ID: 11712064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
    Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
    Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
    Berg M; Ros AM
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy.
    Nørgaard M; Hueg B; Staberg B
    Photodermatol; 1985 Aug; 2(4):252-6. PubMed ID: 3903679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to DNA modified by 8-methoxypsoralen and ultraviolet A light.
    Santella RM; Dharmaraja N; Gasparro FP; Edelson RL
    Nucleic Acids Res; 1985 Apr; 13(7):2533-44. PubMed ID: 4000963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of DNA and chromosome damage in skin fibroblasts and blood lymphocytes from psoriasis patients treated with 8-methoxypsoralen and UVA irradiation.
    Bredberg A; Lambert B; Lindblad A; Swanbeck G; Wennersten G
    J Invest Dermatol; 1983 Aug; 81(2):93-7. PubMed ID: 6875304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phototherapy and photopharmacology.
    Gasparro FP; Chan G; Edelson RL
    Yale J Biol Med; 1985; 58(6):519-34. PubMed ID: 3832664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PUVA therapy: decrease of the 8-methoxypsoralen level following local administration].
    Meffert H; Metz D
    Dermatol Monatsschr; 1980 Aug; 166(8):566-7. PubMed ID: 7461250
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Methoxy psoralen, etretinate, and UVA for psoriasis.
    Lane-Brown M
    Int J Dermatol; 1987 Dec; 26(10):655-9. PubMed ID: 3429102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
    Aubin F; Makki S; Humbert P; Muret P; Agache P
    Arch Dermatol Res; 1994; 286(1):30-4. PubMed ID: 8141609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of treatment with UV-light (365 nm) and 8-methoxypsoralen on chromosomes of healthy persons and psoriatic patients.
    Löber G; Kittler L; Beensen V; Schaarschmidt H; Knopf B
    Biomed Biochim Acta; 1986; 45(3):343-51. PubMed ID: 3707553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.